The mechanism of PCP in preventing the development of NASH may be associated with the modulation of intestinal microbiota and the downregulation of the NF-κB/CCL3/CCR1 axis. The gene discussed is CCR1; the disease is metabolic dysfunction-associated steatohepatitis.